{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:42:54Z","timestamp":1785544974758,"version":"3.56.0"},"reference-count":40,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polypharmacy is increasingly common across all age groups and is often associated with the use of potentially inappropriate medications (PIMs), where harms may outweigh benefits, contributing to increased adverse drug events, reduced quality of life, and rising health care costs. However, existing deprescribing guidelines and PIM criteria, such as the Beers Criteria and STOPP\/START (Screening Tool of Older Persons\u2019 Prescriptions\/Screening Tool to Alert to Right Treatment), primarily target older adults, overlooking the risks faced by younger populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to develop an international consensus-based list of PIMs for adults aged 18 to 65 years through a modified Delphi process, addressing a critical gap in medication safety and deprescribing guidance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A 14-member international steering committee developed a preliminary list of candidate PIMs through a literature review and expert input. An international, interdisciplinary Delphi panel of 30 to 40 participants will evaluate this list across 3 survey rounds. Panelists will rate the relevance of potential PIMs using predefined criteria, including the balance of benefits and harms, patient preferences, and the availability of alternatives. Consensus will be defined as a median rating of \u22654 (for inclusion) or \u22642 (for exclusion) on a 5-point Likert scale (1=not relevant to 5=extremely relevant), with an IQR width of \u22641 and at least 70% directional agreement. Items not meeting thresholds will be carried forward to subsequent rounds for reconsideration. Quantitative analyses will summarize ratings and agreement levels, while qualitative free-text responses will undergo content analysis to provide context and capture nuanced perspectives. The process will yield a prioritized list of PIMs for adults aged 18 to 65 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Panel recruitment was completed between September and October 2025, with 36 participants. Three rounds of data collection were completed between October 2025 and January 2026. Interim analyses were conducted to inform structured feedback between rounds. Final data analysis is ongoing, and consensus results are expected to be reported in late 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This Delphi process will yield a consensus-based list of PIMs for adults aged 18 to 65 years, informing the development of an international guideline to support safer prescribing practices and to expand deprescribing efforts beyond geriatric care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/92082","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:54:07Z","timestamp":1783108447000},"page":"e92082-e92082","source":"Crossref","is-referenced-by-count":0,"title":["Identification of Potentially Inappropriate Medications for Adults Below 65 Years: Protocol for a Modified Delphi Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9542-0685","authenticated-orcid":false,"given":"Eva","family":"Filosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5530-8502","authenticated-orcid":false,"given":"Nicole","family":"Sch\u00f6nenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4494-5028","authenticated-orcid":false,"given":"Utibe R","family":"Essien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4576-6336","authenticated-orcid":false,"given":"Camille","family":"Gagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9404-3401","authenticated-orcid":false,"given":"Danijela","family":"Gnjidic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0927-7295","authenticated-orcid":false,"given":"Lisa","family":"Kouladjian O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3747-0087","authenticated-orcid":false,"given":"Elizabeth","family":"Manias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9087-1077","authenticated-orcid":false,"given":"Lisa M","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9838-3625","authenticated-orcid":false,"given":"Frank","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6023-8892","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Nguyen-Soenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7669-0632","authenticated-orcid":false,"given":"Sion","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-9480","authenticated-orcid":false,"given":"Michael A","family":"Steinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9724-1422","authenticated-orcid":false,"given":"Petra A","family":"Th\u00fcrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5180-0831","authenticated-orcid":false,"given":"Marnie Goodwin","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca J","family":"Gutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-616X","authenticated-orcid":false,"given":"Arielle","family":"Mendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8479-6656","authenticated-orcid":false,"given":"Emilie","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2267-4239","authenticated-orcid":false,"given":"Todd C","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0783-0624","authenticated-orcid":false,"given":"Emily G","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"nov28 1","key":"R1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f7033","article-title":"Polypharmacy: a necessary evil","volume":"347","author":"Wise","journal-title":"BMJ"},{"issue":"14","key":"R2","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/archinte.1997.00440350031003","article-title":"Explicit criteria for determining potentially inappropriate medication use by the elderly. An update","volume":"157","author":"Beers","journal-title":"Arch Intern Med"},{"issue":"11","key":"R3","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1111\/jgs.19164","article-title":"The cost of potentially inappropriate medications for older adults in Canada: a comparative cross-sectional study","volume":"72","author":"Huon","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"R4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott","journal-title":"JAMA Intern Med"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6904-10-16","article-title":"Increasing polypharmacy\u2014an individual-based study of the Swedish population 2005-2008","volume":"10","author":"Hovstadius","journal-title":"BMC Clin Pharmacol"},{"issue":"3","key":"R6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214240","article-title":"Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States","volume":"14","author":"Oktora","journal-title":"PLoS One"},{"issue":"17","key":"R7","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","journal-title":"JAMA"},{"issue":"7","key":"R8","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","author":"By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"R9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3","volume":"14","author":"O\u2019Mahony","journal-title":"Eur Geriatr Med"},{"issue":"5","key":"R10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40266-023-01024-6","article-title":"The EURO-FORTA (Fit fOR The Aged) list version 2: consensus validation of a clinical tool for improved pharmacotherapy in older adults","volume":"40","author":"Pazan","journal-title":"Drugs Aging"},{"key":"R11","unstructured":"Drug use among seniors in Canada. Canadian Institute for Health Information. URL: https:\/\/www.cihi.ca\/en\/drug-use-among-seniors-in-canada [Accessed 03-10-2025]"},{"key":"R12","unstructured":"Aging in place. CDA-AMC (Canada\u2019s Drug Agency\u2013L\u2019Agence des m\u00e9dicaments du Canada). 2025. URL: https:\/\/www.cda-amc.ca\/aging-place [Accessed 12-06-2026]"},{"issue":"3","key":"R13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2021-001509","article-title":"Deprescribing for all: a narrative review identifying inappropriate polypharmacy for all ages in hospital settings","volume":"10","author":"Elbeddini","journal-title":"BMJ Open Qual"},{"issue":"4","key":"R14","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.1016\/S2666-7568(24)00007-2","article-title":"Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review","volume":"5","author":"Nicholson","journal-title":"Lancet Healthy Longev"},{"issue":"4","key":"R15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/ajg.2018.29","article-title":"Discontinuing long-term PPI therapy: why, with whom, and how?","volume":"113","author":"Targownik","journal-title":"Am J Gastroenterol"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069211","article-title":"Reduce unnecessary use of proton pump inhibitors","volume":"379","author":"Farrell","journal-title":"BMJ"},{"issue":"2","key":"R17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/anae.15808","article-title":"How to conduct a Delphi consensus process","volume":"78","author":"Savic","journal-title":"Anaesthesia"},{"key":"R18","unstructured":"RAND methodological guidance for conducting and critically appraising Delphi panels. RAND. 2023. URL: https:\/\/www.rand.org\/pubs\/tools\/TLA3082-1.html [Accessed 12-06-2026]"},{"issue":"8","key":"R19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304651","article-title":"Delphi studies in social and health sciences\u2014recommendations for an interdisciplinary standardized reporting (DELPHISTAR). Results of a Delphi study","volume":"19","author":"Niederberger","journal-title":"PLoS ONE"},{"issue":"1","key":"R20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004326","article-title":"ACCORD (ACcurate COnsensus Reporting Document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi","volume":"21","author":"Gattrell","journal-title":"PLoS Med"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111485","article-title":"Sample size in multistakeholder Delphi surveys: at what minimum sample size do replicability of results stabilize?","volume":"174","author":"Manyara","journal-title":"J Clin Epidemiol"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-37","article-title":"Stability of response characteristics of a Delphi panel: application of bootstrap data expansion","volume":"5","author":"Akins","journal-title":"BMC Med Res Methodol"},{"key":"R23","unstructured":"Canadian Medication Appropriateness and Deprescribing Network (CADeN). URL: https:\/\/www.deprescribingnetwork.ca\/ [Accessed 14-04-2025]"},{"key":"R24","unstructured":"Australian Deprescribing Network (ADeN). URL: https:\/\/www.australiandeprescribingnetwork.com.au\/ [Accessed 14-04-2025]"},{"key":"R25","unstructured":"US Deprescribing Research Network. URL: https:\/\/deprescribingresearch.org\/ [Accessed 14-04-2025]"},{"key":"R26","unstructured":"Network of European Researchers in Deprescribing (NERD). URL: https:\/\/deprescribing.eu\/ [Accessed 14-04-2025]"},{"key":"R27","unstructured":"Understanding safe antidepressant use: in recognition of World Mental Health day. Canadian Medication Appropriateness and Deprescribing Network; 2024. URL: https:\/\/mailchi.mp\/caden-recad\/sept_2024_eng [Accessed 12-06-2026]"},{"key":"R28","unstructured":"Positions and analyses on key issues in medicines policy and healthcare. Prescrire International. 2025. URL: https:\/\/english.prescrire.org\/en\/1256\/3059\/PositionsList.aspx [Accessed 15-05-2025]"},{"issue":"7","key":"R29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00228-015-1860-9","article-title":"The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries","volume":"71","author":"Renom-Guiteras","journal-title":"Eur J Clin Pharmacol"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","journal-title":"J Biomed Inform"},{"issue":"8","key":"R31","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.techfore.2012.04.013","article-title":"Consensus measurement in Delphi studies: review and implications for future quality assurance","volume":"79","author":"von der Gracht","journal-title":"Technol Forecast Soc Change"},{"issue":"1","key":"R32","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.sapharm.2021.06.027","article-title":"\u201cMore of an art than a science\u201d? The development, design and mechanics of the Delphi technique","volume":"18","author":"Drumm","journal-title":"Res Social Adm Pharm"},{"issue":"9","key":"R33","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","journal-title":"Qual Health Res"},{"key":"R34","unstructured":"Patton MQ . Qualitative Research and Evaluation Methods. 3rd ed. Sage Publications; 2002. URL: https:\/\/aulasvirtuales.wordpress.com\/wp-content\/uploads\/2014\/02\/qualitative-research-evaluation-methods-by-michael-patton.pdf [Accessed 12-06-2026]"},{"issue":"6","key":"R35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4082\/kjfm.22.0178","article-title":"Recent advance in clinical practice guideline development methodology","volume":"43","author":"Kim","journal-title":"Korean J Fam Med"},{"key":"R36","unstructured":"Deprescribing guidelines and algorithms. Deprescribing.org. URL: https:\/\/deprescribing.org\/resources\/deprescribing-guidelines-algorithms\/ [Accessed 14-04-2025]"},{"issue":"8","key":"R37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161248","article-title":"Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing","volume":"11","author":"Farrell","journal-title":"PLoS One"},{"issue":"12","key":"R38","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.7326\/M21-3034","article-title":"The future of medical guidelines: standardizing clinical care with the humility of uncertainty","volume":"174","author":"Spellberg","journal-title":"Ann Intern Med"},{"issue":"7650","key":"R39","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","journal-title":"BMJ"},{"key":"R40","unstructured":"Charter. WikiGuidelines. URL: https:\/\/wikiguidelines.org\/charter [Accessed 14-04-2025]"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e92082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:24:00Z","timestamp":1785536640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e92082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":40,"URL":"https:\/\/doi.org\/10.2196\/92082","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"article-number":"v15inov28 1e92082"}}